Eli Lilly has not filed a New Drug Application with the FDA as of May 2026
Enzalutamide has also been tested in patients with clinically nonmetastatic, hormone-resistant prostate cancer (defined as PSA doubling time 10 months while undergoing hormonal therapy).[35] In the double-blind phase III PROSPER trial (NCT02003924), 1,401 men without clinical metastases on imaging, but with a rapidly rising PSA, were randomly assigned in a 2:1 ratio to receive either enzalutamide (160 mg PO qd) or placebo
Youll learn how it compares to FDA-approved options like Ozempic and Wegovy, what side effects users commonly report, and whether it's worth considering for your weight loss journey
(Pressure can also be adjusted by tightening or loosening straps.) How to care for Aircast SP Walking Brace/Walker Boot
Others pursue B12 injections for wellness optimizationsupporting energy levels, cognitive function, metabolism, and overall vitality even without diagnosed deficiency